Clinical Trial Update: A Study to Learn About Two or More Vaccines That Are Put Together as One Shot Against Infectious Lung Illnesses, Including COVID-19 and Respiratory Syncytial Virus (RSV). [Phase 2]

View source ↗

Summary

Pfizer completed a Phase 2 trial evaluating a single-shot combination vaccine for COVID-19 and Respiratory Syncytial Virus (RSV); results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syncytial Virus Infection

Drugs mentioned

• Pfizer two-in-one vaccine (COVID-19 and RSV) combination

Snippet

Sponsor: Pfizer | Conditions: Healthy Participants | Phase 2 | Status: COMPLETED | Results posted: 2024-12-18